AATS: American Association for Thoracic Surgery.
Watch the AATS Leadership Video
 
Survival after Transapical and Transarterial Aortic Valve Implantation: Talking about Two Different Patient Populations
Sabine Bleiziffer, Hendrik Ruge, Domenico Mazzitelli, Christian Schreiber, Andrea Hutter, Robert Bauernschmitt, Ruediger Lange; Clinic for Cardiovascular Surgery, German Heart Center Munich, Munich, Germany

Objective: Recently, suspicion rose that survival may be impaired after antegrade transapical valve implantation in high-risk patients with aortic stenosis compared to the retrograde transarterial access. We analyzed survival in patients undergoing transcatheter aortic valve implantation with regard to implantation technique.
Methods: Between 06/2007 and 09/2008, 153 high-risk patients (EuroScore 24±14%, mean age 81±8y) underwent transcatheter aortic valve implantation transapically (n=27) or transarterially (n=123 transfemoral, n=3 via subclavian artery). The transapical implantation technique was chosen only in patients who had no access through diseased femoral or subclavian arteries.
Results: 30-day survival was 89.9% after transarterial vs 79.1% after transapical implantation (p=0.028, see survival curve). The transapical group had a significantly higher preoperative BNP value, and a significantly higher incidence of peripheral vessel and cerebrovascular disease, pulmonary hypertension, and atrioventricular valve regurgitation. Death was valve-related in 25% (transapical) and 29% (transarterial), cardiac in 13% and 10%, and non-cardiac in 63% and 62%, respectively (n.s.). In the transapical group, there were significantly less postoperative vascular complications (4% vs 20%, p=0.009), and no neurological events (0% vs 6.5%, n.s.).
Conclusion: Survival is worse in patients in whom transapical, as opposed to transarterial aortic valve implantation is necessary, because these patients exhibit a significantly higher incidence of comorbidities. The causes of death were not different in the two groups, however, more patients in the transapical group succumb during follow-up. On the other hand, cerebrovascular complications did not occur in patients with transapical access.


Back to 2009 Annual Meeting
Back to Program Outline
Back to Main Program
We Model Excellence
Follow AATS on Facebook
Copyright © American Association for Thoracic Surgery. All rights reserved.
Read the Privacy Policy.
IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.